Premium
Vaxart Inc (VXRT)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory sync... Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.23345 | -31.1225169977 | 0.7501 | 0.77 | 0.45 | 1529922 | 0.71812054 | CS |
| 4 | -0.25335 | -32.9025974026 | 0.77 | 0.7999 | 0.45 | 1200091 | 0.72006561 | CS |
| 12 | -0.09575 | -15.6352057479 | 0.6124 | 0.9799 | 0.45 | 1715980 | 0.71951316 | CS |
| 26 | -0.44835 | -46.4611398964 | 0.965 | 1.07 | 0.45 | 1524613 | 0.75133926 | CS |
| 52 | -0.74335 | -58.996031746 | 1.26 | 1.41 | 0.45 | 2266979 | 0.76039464 | CS |
| 156 | -3.46335 | -87.0188442211 | 3.98 | 5.43 | 0.45 | 2187109 | 1.62610604 | CS |
| 260 | -0.66335 | -56.2161016949 | 1.18 | 24.9 | 0.45 | 6649179 | 6.83034308 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
